Healthcare Industry News:  Smiths Medical 

Devices FDA

 News Release - March 20, 2008

Smiths Medical Receives FDA Clearance for Next Generation CADD(R)-Solis Ambulatory Infusion System

New "smart" patient-centered ambulatory infusion system brings breakthrough advancements in medication safety and personalized patient care to pain management in the hospital setting

ST. PAUL, Minn.--(HSMN NewsFeed)--Smiths Medical, part of the global technology business Smiths Group, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CADD®-Solis Ambulatory Infusion System, a clinically and technologically advanced next generation ambulatory infusion platform that enhances patient safety and personalized care for pain management patients.

Ambulatory infusion systems, like the CADD®-Solis system, administer pain management medications, including narcotics, via a variety of delivery routes including intravenous (I.V.) and epidural. It is critical for these devices to have safeguards such as safety software and intuitive programming options to help clinicians care for their pain management patients.

“Improving patient safety and the quality of care is our first priority,” said Jim Stitt, President of Smiths Medical MD. “By involving both clinicians and the Human Factors Engineering team at the University Health Network in Toronto in all phases of the development process, we strove to design a safe, easy-to-use system that brings exceptional value in helping hospitals reduce the risk of programming medication errors while providing better patient care management.”

The CADD®-Solis Ambulatory Infusion System includes:
  • CADDD-Solis Ambulatory Infusion Pump
  • CADD®-Solis Medication Safety Software
  • CADD™ Medication Cassette Reservoirs and Administration Sets
The CADD®-Solis Ambulatory Infusion Pump is small and lightweight to promote patient mobility and clinician convenience. The versatile pump can be used for a variety of pain management therapies and patients. Its large color graphic display screen helps clinicians view and verify pump programs, identify and respond to alarms and interpret delivery trends and patient activity. The pump’s task-based software and cell-phone design is familiar to users, promoting ease of use and safety. The scalable, adaptable platform is designed to satisfy hospital’s current and future clinical requirements and health information technology initiatives. CADD®-Solis system innovations are built on the foundation of reliable CADD® pump technology proven over 25 years of global service.

The CADD®-Solis Medication Safety Software is an innovative therapy-based medication safety system designed to deploy the customer’s current best practice pain management protocols to help reduce the risk of adverse drug events (ADEs) and promote clinician confidence. The safety software allows hospitals to create their own standardized pain management protocols, including, “hard” and “soft” programming limits to help prevent medication errors. The protocols are downloaded directly into each CADD®-Solis pump so a clinician can easily select the specific pain management protocol for each patient’s individual therapy needs. By allowing clinicians to select only the standard protocol information that is pre-determined by hospital administrators, the risk of programming and medication errors can be greatly reduced.

CADD™ Medication Cassette Reservoirs are unique to CADD® ambulatory infusion systems, providing a compact, durable, self-contained medication reservoir to promote patient mobility and drug security. CADD® administration sets are also available for medication delivery from an IV bag.

“CADD® ambulatory infusion systems have defined home infusion therapy and ambulatory pain management over the past 25 years and continue to serve today’s patients and providers. The CADD®-Solis system enables customers to envision and fulfill the future of ambulatory infusion technology,” said Stitt. “The system will help to expand the ‘smart’ ambulatory infusion market, bringing patient safety and personalized patient care to hospital customers today and to our home infusion therapy and outpatient oncology customers in the near future.”

The CADD®-Solis ambulatory infusion system is backed by Smiths Medical’s reputation as a leading provider of medication delivery and patient safety products worldwide, with more than 300,000 infusion pumps in use in hospitals and alternate sites of care worldwide today.

Smiths Medical

Smiths Medical is a supplier of specialist medical devices to global markets. Smiths Medical comprises three product groupings: Safety Devices, Vital Care and Medication Delivery. Smiths Medical customers include hospitals and other healthcare providers worldwide. Smiths Medical employs nearly 7,500 people. For further information visit www.smiths-medical.com

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange. A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs more than 20,000 people in over 50 countries. For more information visit www.smiths.com


Source: Smiths Medical

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.